oral TLR7 agonist RG7854 and HBV core protein allosteric modulator RG7907. Dicerna is retaining an option to co-fund pivotal development of the product globally, which would entitle the company to ...
PRMT1, arginine methyltransferase 1; CBP, CREB binding protein; HDAC1, histone deacetylase 1; SIRT3, sirtuin 3; HAT1, histone acetyltransferase 1. Chronic hepatitis B virus (HBV) infection continues ...
The L-protein consists of the S ... To learn more about Creative Diagnostics' HBV Core Antigens, HBV Surface Antigens, HBV E Antigens and different subtypes of HBV antigens, and other research ...
an HBV-targeting siRNA; BRII-179, a recombinant protein-based HBV immunotherapeutic. The Company's partner, Vir Biotechnology, is also progressing multiple combination studies with elebsiran and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback